NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

RedCord in Neurogenic Bowel Dysfunction in Multiple Sclerosis
RedCord in Neurogenic Bowel Dysfunction in Multiple Sclerosis

NCT06838624

Not Yet RecruitingNA

Sponsor: University of Castilla-La Mancha

Conditions: Multiple Sclerosis, Pelvic Floor Disorder

Interventions: Redcord, Control (Standard treatment)

Countries: Spain

The study aims to evaluate the effectiveness of Redcord treatment for neurogenic bowel dysfunction in patients with multiple sclerosis. The main objectives are: * Assess the impact of Redcord on bowel function and quality of life in multiple sclerosis patients. * Compare the outcomes of Redcord treatment with standard care practices. Participants will undergo Redcord therapy sessions and their bowel function will be monitored and compared to a control group receiving standard care. The study will measure improvements in bowel control, frequency, and overall patient satisfaction.

Eligibility overview

Sex: ALL

Age: 30 Years to 60 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* People diagnosed with Multiple Sclerosis according to McDonald's criteria.
* EDSS less than 6 points.
* Willingness to participate.

Exclusion Criteria:

* People with cognitive impairment, which makes it difficult to understand the questionnaires properly.
* Pregnant women.
* Severe psychological or psychiatric pathology diagnosed.
Locations (1)
  • Toledo, Toledo, Spain